4.5 Article

Infantile-Onset Isolated Neurohypophyseal Langerhans Cell Histiocytosis with Central Diabetes Insipidus: A Case Report

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Neoplastic Etiology and Natural Course of Pituitary Stalk Thickening

Dong Yeong Kim et al.

Summary: This study investigated the neoplastic etiology and natural course of pituitary stalk thickening (PST). The results showed that PST is commonly caused by tumors, especially in pediatric populations. Follow-up imaging is essential for monitoring disease progression in initially indeterminate cases.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity

Kazutaka Morota et al.

Summary: This case report highlights the use of Rab3A-Ab as a useful adjunctive diagnostic tool for childhood-onset lymphocytic infundibulo-hypophysitis (LIH), which can be misdiagnosed as central diabetes insipidus (CDI) with a thickened pituitary stalk.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2022)

Article Oncology

Diagnostic Capability of Cerebrospinal Fluid-Placental Alkaline Phosphatase Value in Intracranial Germ Cell Tumor

Michinari Okamoto et al.

Summary: The CSF-PLAP value is a useful biomarker for the initial diagnosis and recurrence of IGCTs, and may be associated with the volume of germinomatous components of tumors.

ONCOLOGY (2021)

Review Pediatrics

Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline

Manuela Cerbone et al.

Summary: Unexplained or idiopathic pituitary stalk thickening or central diabetes insipidus may indicate rare occult malignancies or benign congenital defects. Proper evaluation and management strategies are necessary to improve outcomes and validate the systematic approach outlined in the guidelines.

LANCET CHILD & ADOLESCENT HEALTH (2021)

Article Oncology

FDG PET-CT in pediatric Langerhans cell histiocytosis

Sophie Jessop et al.

PEDIATRIC BLOOD & CANCER (2020)

Review Hematology

Langerhans cell histiocytosis

Carlos Rodriguez-Galindo et al.

BLOOD (2020)

Article Clinical Neurology

ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients

Anandani Nellan et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Article Endocrinology & Metabolism

Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report

Weibin Zhou et al.

BMC ENDOCRINE DISORDERS (2019)

Review Endocrinology & Metabolism

Pituitary stalk lesions: systematic review and clinical guidance

Sarah Catford et al.

CLINICAL ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis

Shintaro Iwama et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Review Pediatrics

Recent advances in Langerhans cell histiocytosis

Akira Morimoto et al.

PEDIATRICS INTERNATIONAL (2014)

Article Endocrinology & Metabolism

Pituitary Stalk Lesions: The Mayo Clinic Experience

Adina F. Turcu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Oncology

Predictors of neoplastic disease in children with isolated pituitary stalk thickening

Nathan J. Robison et al.

PEDIATRIC BLOOD & CANCER (2013)

Article Oncology

Risk factors for diabetes insipidus in langerhans cell histiocytosis

N Grois et al.

PEDIATRIC BLOOD & CANCER (2006)

Article Medicine, General & Internal

Central diabetes insipidus in children and young adults

M Maghnie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Article Clinical Neurology

Langerhans cell histiocytosis limited to the pituitary-hypothalamic axis - Two case reports

A Isoo et al.

NEUROLOGIA MEDICO-CHIRURGICA (2000)